Search Within

Department of Medicine

Formats
  1. Journal Article (19590)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22319)
  2. Hematologic Malignancies, Division of (13274)
  3. Center for Hematologic Malignancies (11058)
  4. GSK Faculty (10645)
  5. Survivorship Research (9329)
  6. Division of Subspecialty Medicine (7534)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1064)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concordance between human epidermal growth factor receptor 2 (HER2) status by immunohistochemistry (IHC) and next-generation sequencing (NGS) in tissue and blood samples from gastric and gastroesophageal junction cancers (GC/GEJC)
    Meeting Abstract

    Maron, S. B.; Burke, K.; Gupta, P.; Sarlo, K.; Tesic-Schnell, M.; Woo, M. S. A.; Klempner, S. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC)
    Meeting Abstract

    Trueman, S.; Wu, L.; Girgis, S.; Vaidya, K.; Meric-Bernstam, F.; Harding, J. J.; Pant, S.; Zhao, Y.; Garfin, P. M.; Iannone, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between immune-related adverse events and prognosis after immune checkpoint inhibitor in hepatocellular carcinoma: A meta-analysis and systematic review
    Meeting Abstract

    Hwang, S. Y.; Rezaee-Zavareh, M. S.; Attia, A. M.; Kaymen, E.; Tran, N. H.; Abou-Alfa, G. K.; Singal, A.; Yang, J. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Adagrasib (Ada) + cetuximab (Cetux) for KRAS(G12C)-mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1
    Meeting Abstract

    Yaeger, R.; Uboha, N. V.; Klempner, S. J.; Bekaii-Saab, T. S.; Sabari, J. K.; Barve, M. A.; Saltzman, J. N.; Peguero, J. A.; Paulson, A. S.; Jänne, P. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC)
    Meeting Abstract

    Sreeram, A.; Yeh, C.; Toumbacaris, N.; Capanu, M.; Shimada, S.; Gu, P.; Janjigian, Y. Y.; Ilson, D. H.; Strong, V. E.; Ku, G. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649
    Meeting Abstract

    Janjigian, Y. Y.; Moehler, M. H.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo, C.; Wyrwicz, L.; Yamaguchi, K.; Cleary, J. M.; Elimova, E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Frakes, J. M.; Wu, A. J. C.; Miller, E. D.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlation between disease-free survival endpoints and overall survival in elderly patients with early-stage HER2-negative breast cancer: A SEER-medicare analysis
    Journal Article

    Earla, J. R.; Kurian, A. W.; Kponee-Shovein, K.; Mahendran, M.; Song, Y.; Hua, Q.; Hilts, A.; Sun, Y.; Hirshfield, K. M.; Robson, M.; more...
    Advances in Therapy (2025)

    Fulltext@MSK | Save
  • Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM)
    Meeting Abstract

    Fakih, M.; Segal, N. H.; Schlechter, B. L.; Andre, T.; Pietrantonio, F.; Johnson, B.; Vasilyev, A.; Krishnamurthi, S. S.; Siena, S.; Messersmith, W. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save